Structural racism and limited resources can pose barriers to type 2 diabetes care in Black patients. A Black physician and ...

Berberine ursodeoxycholate, a novel gut-liver metabolic modulator, reduces A1c levels and improves glycemic, cardiometabolic, ...

Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...

Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...

Learn about diabetes types, symptoms, causes, and management in this comprehensive guide. Empower yourself with knowledge to ...

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...

Discover simple lifestyle changes backed by research that can significantly lower your type 2 diabetes risk without requiring ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

Glenmark launches Empagliflozin and combinations in India under Glempa brand, aiming to improve glycemic control and reduce ...